53 related articles for article (PubMed ID: 32361033)
21. Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.
Wu S; Zhan W; Liu L; Xie D; Yao L; Yao H; Liao G; Huang L; Zhou Y; You P; Huang Z; Li Q; Xu B; Wang S; Wang G; Zhang DK; Qiao G; Chan LW; Lanuti M; Zhou H
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37865396
[TBL] [Abstract][Full Text] [Related]
22. Tumor infiltrating lymphocytes and radiological picture of the tumor.
Frankowska K; Zarobkiewicz M; Dąbrowska I; Bojarska-Junak A
Med Oncol; 2023 May; 40(6):176. PubMed ID: 37178270
[TBL] [Abstract][Full Text] [Related]
23. Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians.
Zhou H; Luo Q; Wu W; Li N; Yang C; Zou L
Front Immunol; 2023; 14():1088874. PubMed ID: 36936913
[TBL] [Abstract][Full Text] [Related]
24. Prediction of CD3 T cells and CD8 T cells expression levels in non-small cell lung cancer based on radiomic features of CT images.
Chen L; Chen L; Ni H; Shen L; Wei J; Xia Y; Yang J; Yang M; Zhao Z
Front Oncol; 2023; 13():1104316. PubMed ID: 36860311
[TBL] [Abstract][Full Text] [Related]
25. The radiological appearances of lung cancer treated with immunotherapy.
Milanese G; Mazzaschi G; Ledda RE; Balbi M; Lamorte S; Caminiti C; Colombi D; Tiseo M; Silva M; Sverzellati N
Br J Radiol; 2023 Mar; 96(1144):20210270. PubMed ID: 36367539
[TBL] [Abstract][Full Text] [Related]
26. Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumor subsampling strategies.
Henry T; Sun R; Lerousseau M; Estienne T; Robert C; Besse B; Robert C; Paragios N; Deutsch E
Sci Rep; 2022 Oct; 12(1):17244. PubMed ID: 36241749
[TBL] [Abstract][Full Text] [Related]
27. Radiomic Signatures Associated with CD8
Ramlee S; Hulse D; Bernatowicz K; Pérez-López R; Sala E; Aloj L
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954318
[TBL] [Abstract][Full Text] [Related]
28. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
Front Immunol; 2022; 13():859323. PubMed ID: 35572597
[TBL] [Abstract][Full Text] [Related]
29. A Radiomic Approach to Access Tumor Immune Status by CD8
Min J; Dong F; Wu P; Xu X; Wu Y; Tan Y; Yang F; Chai Y
Onco Targets Ther; 2021; 14():4921-4931. PubMed ID: 34611410
[TBL] [Abstract][Full Text] [Related]
30. A Low-Dose CT-Based Radiomic Model to Improve Characterization and Screening Recall Intervals of Indeterminate Prevalent Pulmonary Nodules.
Rundo L; Ledda RE; di Noia C; Sala E; Mauri G; Milanese G; Sverzellati N; Apolone G; Gilardi MC; Messa MC; Castiglioni I; Pastorino U
Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573951
[TBL] [Abstract][Full Text] [Related]
31. Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma.
Bian Y; Liu YF; Jiang H; Meng Y; Liu F; Cao K; Zhang H; Fang X; Li J; Yu J; Feng X; Li Q; Wang L; Lu J; Shao C
Abdom Radiol (NY); 2021 Oct; 46(10):4800-4816. PubMed ID: 34189612
[TBL] [Abstract][Full Text] [Related]
32. XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8
Li J; Shi Z; Liu F; Fang X; Cao K; Meng Y; Zhang H; Yu J; Feng X; Li Q; Liu Y; Wang L; Jiang H; Lu J; Shao C; Bian Y
Front Oncol; 2021; 11():671333. PubMed ID: 34094971
[TBL] [Abstract][Full Text] [Related]
33. Additional Value of PET/CT-Based Radiomics to Metabolic Parameters in Diagnosing Lynch Syndrome and Predicting PD1 Expression in Endometrial Carcinoma.
Wang X; Wu K; Li X; Jin J; Yu Y; Sun H
Front Oncol; 2021; 11():595430. PubMed ID: 34055595
[TBL] [Abstract][Full Text] [Related]
34. A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma.
Ma Q; Chen Y; Xiao F; Hao Y; Song Z; Zhang J; Okuda K; Um SW; Silva M; Shimada Y; Si C; Liang C
Transl Lung Cancer Res; 2021 Mar; 10(3):1484-1500. PubMed ID: 33889524
[TBL] [Abstract][Full Text] [Related]
35. Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC.
Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Lung Cancer; 2020 Jun; 144():30-39. PubMed ID: 32361033
[TBL] [Abstract][Full Text] [Related]
36. Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients.
Trentini F; Mazzaschi G; Milanese G; Pavone C; Madeddu D; Gnetti L; Frati C; Lorusso B; Lagrasta CAM; Minari R; Ampollini L; Ledda RE; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Tumori; 2022 Feb; 108(1):86-92. PubMed ID: 33730957
[TBL] [Abstract][Full Text] [Related]
37. Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer.
Mazzaschi G; Milanese G; Pagano P; Madeddu D; Gnetti L; Trentini F; Falco A; Frati C; Lorusso B; Lagrasta C; Minari R; Ampollini L; Silva M; Sverzellati N; Quaini F; Roti G; Tiseo M
Data Brief; 2020 Aug; 31():105781. PubMed ID: 32548224
[TBL] [Abstract][Full Text] [Related]
38. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
40. Radiomics features as predictive and prognostic biomarkers in NSCLC.
Bortolotto C; Lancia A; Stelitano C; Montesano M; Merizzoli E; Agustoni F; Stella G; Preda L; Filippi AR
Expert Rev Anticancer Ther; 2021 Mar; 21(3):257-266. PubMed ID: 33216651
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
